Octreotride in acute pancreatitis - have it or not?
DOI:
https://doi.org/10.21649/akemu.v12i2.899Keywords:
Pancreatitis. Acute Disease. Pancreatitis, Acute Necrotizing. Pancreas. Retrospective Studies. Appendicitis. Cohort Studies. Prospective Studies. Behavior.Abstract
The study was conducted in the Department of Surgery, Mayo Hospital, Lahore from March 2003 to January 2006. The objective of the study was to see the beneficial effects of Octreotride in acute pancreatitis. Thirty five patients who were diagnosed as acute pancreatitis were divided in two groups. In group A (controlled) Octreotride was given in a dose of 100?gm t.i.d subcutaneously for 7-10 days along with other measures. In group B (uncontrolled) patient were managed without Octreotride. Patients were evaluated in terms of abscess formation, haemorrhage, pseudocyst formation and mortality or uneventful recovery in both groups. No beneficial effect of Octreotride was observed in controlled group as compared to uncontrolled group. So we don`t recommend the routine use of Octreotride in patients with acute pancreatitis.
Downloads
Published
How to Cite
Issue
Section
License
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk